Histone Deacetylase Inhibitors — Epidrugs for Neurological Disorders
This book provides an outline of epigenetics as a whole, while also specifically examining a range of epigenetic players, including histone acetyl transferases (HATs) and histone deacetylases (HDACs). It chiefly focuses on the emerging targets of HDACs and their implications for various neurological...
Main Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Singapore
Springer Nature Singapore
2019, 2019
|
Edition: | 1st ed. 2019 |
Subjects: | |
Online Access: | |
Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Chapter 1. Role of Epigenetics in neurological diseases
- Chapter 2. Epigenetic enzymes and the drawbacks of conventional therapeutic regimens
- Chapter 3. Distinct classes of HDACs
- Chapter 4. HDAC implications in neurological diseases
- Chapter 5. HDAC inhibitors and their structurally distinct groups
- Chapter 6. HDAC inhibitors as novel therapeutic option against therapeutically challenging neurological disorders
- Chapter 7. Current Challenges with HDAC inhibitor based therapeutic intervention against neurological maladies
- Chapter 8. Escalating need of isoform selective inhibitors for enhanced therapeutic efficacy
- Chapter 9. Combinatorial therapeutic regimens using HDAC inhibitors in conjunction with conventional therapeutic agents
- Chapter 10. Future directions of epigenetic research in tackling neurological complications